These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20875261)

  • 21. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    BMJ; 1991 Oct; 303(6807):893-6. PubMed ID: 1933004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial hypercholesterolemia: clinical aspects].
    Ciarrocchi A; Gaddi A; Rimondi S; Mezzetti M; Scaramuzzino G
    Cardiologia; 1988 Nov; 33(11):1055-60. PubMed ID: 3255492
    [No Abstract]   [Full Text] [Related]  

  • 23. Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999.
    Scott Med J; 1999 Jun; 44(3):73-4. PubMed ID: 10461692
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surgery for ischemic heart disease secondary to familial hyperlipidemia].
    Hiroshi O; Kenzo Y; Masaharu M; Fumihiko Y; Shigeru H; Toshio A; Yutaka O; Akira S
    Kokyu To Junkan; 1985 Mar; 33(3):463-8. PubMed ID: 3874410
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial hypercholesterolaemia: A guide for general practice.
    Brett T; Arnold-Reed D
    Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects].
    Walter-Rosianu A
    Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aortocoronary bypass surgery in an 18 year-old woman with severe hypercholesterolemia (familial hyperlipoproteinemia IIa, homozygote) (author's transl)].
    Kitamura S; Mori T; Nakano S; Miyamoto K; Kawachi K; Sakakibara T; Hotta T; Kawashima Y; Yamamoto A
    Kokyu To Junkan; 1980 Oct; 28(10):1183-9. PubMed ID: 6971462
    [No Abstract]   [Full Text] [Related]  

  • 28. [Imbalance of the plasma proteinase-inhibitory system in familial hypercholesterolemia].
    Alidzhanova KhG; Ogloblina OG; Kukharchuk VV; Konovalov GA; Parfenkova GA; Belova LA
    Kardiologiia; 1989 Jul; 29(7):115-6. PubMed ID: 2811031
    [No Abstract]   [Full Text] [Related]  

  • 29. Images in clinical medicine. Xanthomatous pseudospectacles in familial hypercholesterolemia.
    Girish MP; Gupta MD
    N Engl J Med; 2005 Jun; 352(23):2424. PubMed ID: 15944427
    [No Abstract]   [Full Text] [Related]  

  • 30. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.
    Wiklund O; Angelin B; Olofsson SO; Eriksson M; Fager G; Berglund L; Bondjers G
    Lancet; 1990 Jun; 335(8702):1360-3. PubMed ID: 1971660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation of coronary risk factors in families of men with fatal and non-fatal coronary heart disease.
    Rissanen AM; Nikkilä EA
    Br Heart J; 1979 Oct; 42(4):373-80. PubMed ID: 508467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Fiberform, a low-phytate wheat fibre, on plasma lipids and blood pressure of women with familial hypercholesterolaemia.
    Lansberg PJ; Knipscheer HC; Kastelein JJ; Prins MH; van der Ende AE
    J Intern Med; 1994 Oct; 236(4):477-8. PubMed ID: 7931053
    [No Abstract]   [Full Text] [Related]  

  • 33. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of subclinical atherosclerosis by electron beam tomography in females with heterozygous familial hypercholesterolaemia.
    Santos RD; Meneghelo RS; Chacra AP; Martinez TL; Ramires JA; Carvalho JA
    Heart; 2004 Jan; 90(1):92-4. PubMed ID: 14676254
    [No Abstract]   [Full Text] [Related]  

  • 35. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia.
    Sijbrands EJ; Westendorp RG; Paola Lombardi M; Havekes LM; Frants RR; Kastelein JJ; Smelt AH
    Atherosclerosis; 2000 Apr; 149(2):421-5. PubMed ID: 10729393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alpha-lipoproteins (cholesterol-HDL) in familial heterozygous hypercholesterolemia].
    Moorjani S; Gagné C; Brun LD; Toussaint M; Lupien PJ
    Union Med Can; 1980 Apr; 109(4):530-4. PubMed ID: 7456148
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient profile: familial hypercholesterolaemia.
    Schuster H
    Int J Clin Pract Suppl; 2002 Jul; (130):20-1. PubMed ID: 12296604
    [No Abstract]   [Full Text] [Related]  

  • 38. Dietary and pharmacologic therapy for the lipid risk factors.
    JAMA; 1983 Oct; 250(14):1873-9. PubMed ID: 6620484
    [No Abstract]   [Full Text] [Related]  

  • 39. [Right coronary ostial stenosis in homozygotic hypercholesterolemia. Coronarographic and echocardiographic diagnosis].
    Verdiere C; Drobinski G; Evans JI; Cahen C; de Gennes JL; Thomas D
    Presse Med; 1984 Jul 14-21; 13(29):1770-2. PubMed ID: 6235505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial Hypercholesterolaemia Regression Study and its implications.
    Watts GF
    Lancet; 1995 Apr; 345(8953):807-8. PubMed ID: 7898224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.